The neuromuscular blocking action of 2-(4-phenylpiperidino) cyclohexanol (AH 5183).
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D002645:Chickens; D002794:Choline / Q000494:pharmacology; D003510:Cyclohexanes / Q000008:administration & dosage*; D003964:Diaphragm / Q000187:drug effects; D004558:Electric Stimulation; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000633:toxicity; D010791:Phrenic Nerve / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D010880:Piperidines / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000633:toxicity; D051381:Rats; D013977:Tibia / Q000187:drug effects; D014403:Tubocurarine / Q000008:administration & dosage
D003510:Cyclohexanes; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D001285:Atropine; D010830:Physostigmine; D002794:Choline; D014403:Tubocurarine